Personalized chemosensitivity assays for mesothelioma- is it worth the effort?
| Author | |
|---|---|
| Abstract | :
Cell-lines formed from an individual's tumor can be used to predict response to specific therapies and determine genomic predictors. For mesothelioma, where chemotherapy remains the backbone of current therapeutic paradigms, such assays could be used to treat patients with the most effective agents specific to their "chemical profile". |
| Year of Publication | :
2018
|
| Journal | :
Clinical cancer research : an official journal of the American Association for Cancer Research
|
| Date Published | :
2018
|
| ISSN Number | :
1078-0432
|
| URL | :
http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=29351918
|
| DOI | :
10.1158/1078-0432.CCR-17-3493
|
| Short Title | :
Clin Cancer Res
|
| Download citation |